Previous close | 24.60 |
Open | 24.71 |
Bid | 24.74 x 4000 |
Ask | 24.75 x 900 |
Day's range | 24.56 - 24.97 |
52-week range | 15.07 - 29.51 |
Volume | |
Avg. volume | 5,702,830 |
Market cap | 75.118B |
Beta (5Y monthly) | 1.32 |
PE ratio (TTM) | 3.89 |
EPS (TTM) | 6.36 |
Earnings date | N/A |
Forward dividend & yield | 1.66 (6.74%) |
Ex-dividend date | 22 Apr 2024 |
1y target est | 29.93 |
Earnings preview of key companies reporting next week and what to look out for.
(Bloomberg) -- Novo Nordisk A/S’s reign as Europe’s most valuable company “leaves no room to disappoint” with its first-quarter report, said Bloomberg Intelligence’s Michael Shah.Most Read from BloombergJavier Milei Fuels Wild Rally That Makes Peso No. 1 in WorldPlunging Home Prices, Fleeing Companies: Austin’s Glow Is FadingHuawei’s New Phone Runs Latest Version of Made-in-China ChipUS Economy Slows and Inflation Jumps, Damping Soft-Landing HopesFed’s Preferred Core Inflation Gauge Rose at Bris
In the most recent trading session, Stellantis (STLA) closed at $24.60, indicating a -1.05% shift from the previous trading day.